|
|
|
|
|
by petegrif
5343 days ago
|
|
Wouldn't that be nice. Now consider the case of a pharmaceutical company that has to spend hundreds of millions of dollars to develop a new drug and get it past FDA. If there is no IP protection would you as the CEO of this company spend that kind of money on innovating when the resultant drug could be copied a week after it appears on the shelves? In this case you would be competing on product alright - exactly the same product. But the copier has had no R&D cost and can undercut you and put your offering out of business. The issue is often framed in terms of all patents being bad, or all software patents being bad but to anyone to gives the matter more than the kind of superficial thought stemming from ideology the reality is rather more complicated. |
|